drugset / Trial / NCT04577300
Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma
RandomizedParallel-groupDouble-blindTreatment
Summary
To determine the safety and efficacy over 24 months of dual NT-501 CNTF encapsulated cell therapy (ECT) on visual impairment related to glaucoma.
Timeline
- Start
- 2021-05-15
- Primary completion
- 2025-08-15
- Completion
- 2026-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ciliary neurotrophic factor | Cell therapy | 1 unknown | Intravitreal |
| Subject | Ciliary neurotrophic factor | Cell therapy | 2 unknown | Intravitreal |